iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching iSpecimen (NASDAQ: ISPC) on March 12, 2026 launched an AI-powered Inventory Agent embedded in its redesigned marketplace to accelerate biospecimen request review and matching. The LLM-driven agent extracts criteria from plain-language requests, ranks potential matches, and aims to reduce manual review while retaining expert oversight.The company plans additional AI features for regulatory monitoring, workflow automation, and lead qualification to streamline biospecimen sourcing.

#ISPC iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

www.stocktitan.net/news/ISPC/i-specimen-lau...

Semana intensa: preventivos y formación con la gente mayor, sesiones en el #ISPC, alerta #INUNCAT, #8M, búsqueda de persona desaparecida y tareas internas. Nuestro voluntariado sigue trabajando para la ciudad. 💪🟧 #ProtecciónCivil #SantAdria @ajsantadria.bsky.social

iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement iSpecimen (Nasdaq: ISPC) announced a private placement expected to raise approximately $5.5 million in gross proceeds through the issuance of 6,875 shares of newly designated Series C Convertible Preferred Stock at $800 per share.Each preferred share has a $1,000 stated value and converts into common stock at a conversion price equal to 85% of the closing price of common stock on the trading day before each conversion date. The company intends to use net proceeds for marketing, working capital, and general corporate purposes. Closing is expected on or about December 31, 2025, subject to customary conditions. E.F. Hutton is the exclusive placement agent. The securities are offered in a private placement to accredited investors and the company agreed to file registration statements covering resale of conversion shares.

#ISPC iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement

www.stocktitan.net/news/ISPC/i-specimen-inc...

cours à l' #ISPC avec @hugostus.bsky.social en voisin, comme il se doit #traditionetrituels
Première fois que je ne vois AUCUN dessin sur ses 2 pages de notes.
Hypothèse 1 : il a changé @papesse.bsky.social ?
hypothèse 2 : il est vraiment intéressé par la séance.

En vrai c'est passionnant.

a man is sitting at a desk with a stack of papers . ALT: a man is sitting at a desk with a stack of papers .

A la câpitâle #ISPC. Cette pause paradoxale mensuelle qui met off les activités habituelles pour 3 jours ultra intenses. Mais c'est tellement bon.

iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions iSpecimen (NASDAQ: ISPC) has provided an update on its strategic initiative to integrate digital assets into its business model. The company is pursuing the development of a $200 million corporate treasury reserve based on the Solana blockchain ecosystem. Since its August announcement, ISPC has received approaches from several cryptocurrency companies presenting opportunities in tokenized real-world assets and highly ranked cryptocurrencies.Under CEO Robert Lim's leadership, iSpecimen plans to establish a SOL-based treasury program to diversify its balance sheet and support long-term growth. The company intends to implement a "buy and HODL" strategy, including purchasing Locked SOL at a discount and utilizing staking mechanisms to generate yields. The program will be funded through future capital raises and will include the acquisition of both locked and unlocked SOL through reputable cryptocurrency institutions.

#ISPC iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

www.stocktitan.net/news/ISPC/i-specimen-app...

iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow iSpecimen (NASDAQ: ISPC) has announced plans to establish a $200 million corporate treasury built around Solana cryptocurrency. The biospecimen technology company has partnered with BlockArrow, a digital asset advisory firm, and WestPark Capital to guide this strategic initiative.The treasury will leverage Solana's blockchain ecosystem, chosen for its high throughput, low transaction costs, and enterprise security features. BlockArrow will implement a layered security model including offline cold storage and insured custody through Coinbase Custody, backed by Lloyd's of London.This strategic move represents iSpecimen's commitment to integrating digital assets into its business model and positioning itself as a leader in blockchain adoption within the life sciences sector.

#ISPC iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow

www.stocktitan.net/news/ISPC/i-specimen-to-...

iSpecimen Raises $1.75M in Private Placement: Here's How They'll Spend It Biospecimen marketplace secures $1.75M private placement with $500K earmarked for marketing expansion. Deal closes Aug 1. See full investment terms.

#ISPC iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market

www.stocktitan.net/news/ISPC/i-specimen-inc...

Biospecimen Marketplace iSpecimen Secures $4M Funding: Here's How They'll Spend It Biotech marketplace secures $4M through stock offering at $0.70/share, with funds earmarked for marketing expansion and strategic partnership. Get complete details.

#ISPC iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

www.stocktitan.net/news/ISPC/i-specimen-inc...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with strong volume declines, Wed Jul 16th - #ONCO #NXL #UFG #REBN #MLEC #ISPC #NWTN #PEW #ECX #IKNA #KZR - More: crystalequityresearch.com/SmCpStr/ - #smallcap

#Gaza #solidarity in #Westport #Mayo #Ireland

#StopStarvingGaza #StopArmingIsrael #SanctionIsraelNow
#StopTheGenocide #Genocide #ISPC

youtu.be/n1CjOkB54ag #ISPC

youtu.be/flHbZRJ53c8 #ISPC

🚨 Bearish vibes for #ISPC! Trading at $1.60, it's below key moving averages with RSI under 40, hinting at oversold conditions. MACD stays negative. Consider SHORT at $1.60, target $1.50/$1.40, stop loss $1.70. Watch for vaccine news that could shake things up! 📉 #FeetrAI

🚨 FeetrAI Alert: #ISPC is trading at $1.60, below key SMAs, signaling bearish momentum. RSI <40 suggests oversold, but MACD hints at a short-term bounce. With market volatility high, consider a SHORT at $1.60, targeting $1.50 & $1.40. Stop loss at $1.70. Stay sharp! 📉💡

Aquesta setmana ens hem reunit Estudis Universitaris, Recerca i Innovació de #ISPC per a futures noves col·laboracions
Esperem i desitgem en surtin de noves oportunitats per a la millora de la #seguretat i la #mobilitat al nostre territori
#VirusVial
#SumarParaRestar

Bearish vibes for #ISPC! 📉 Trading at $1.60, with RSI <40 and downward SMA/EMA, it's oversold but vulnerable. MACD hints at hope, yet macro uncertainties loom large. Short at $1.60? Target $1.50/$1.40, stop loss $1.70. Stay cautious, watch the market! #FeetrAI #StockAnalysis

🚨 FeetrAI Alert: #ISPC is trading at $1.60 with bearish signals! RSI < 40 suggests oversold, but MACD hints at a short-term bounce. Market sentiment is cautious; moving averages trend down. Consider SHORT at $1.60, target $1.50/$1.40, stop loss $1.70. Risk management is key! 📉 #Stocks #Trading

Compiler Explorer - ispc (ispc 1.25.3) // Type your code here, or load an example. varying int square_even(varying int num) { if (num % 2 != 0) { return num * num; } else { return num; } } extern "C" uniform in...

Compiler Explorer supports now executing of ISPC! 🥳
ispc.godbolt.org/z/1n9MxYojY #ispc

iSpecimen Secures Critical hMPV Virus Specimens as China Reports Surge in Cases Leading biospecimen marketplace iSpecimen establishes supply chain for human metapneumovirus specimens amid growing concerns over China's respiratory virus outbreak.

#ISPC iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

www.stocktitan.net/news/ISPC/i-specimen-sec...

Just In: ( NASDAQ: #ISPC ) iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

#StockMarket #News

iSpecimen Unveils Major Cancer Biospecimen Initiative, Partners with Leading Genomics Lab for 2025 Growth iSpecimen expands cancer research capabilities through strategic partnerships with U.S. cancer centers and international genomics lab, meeting rising biospecimen demand.

#ISPC iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

www.stocktitan.net/news/ISPC/i-specimen-wil...

JUST IN: ( NASDAQ: #ISPC ) iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

#StockMarket #News

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers iSpecimen (NASDAQ: ISPC) reported positive results from its Next Day Quote (NDQ) Program, a service providing biospecimen sample pricing within 24 hours of customer requests. The program, introduced in 2023, has shown significant traction with 30% of all sales opportunities and 48% of all quotes in November 2024 being NDQ-related. Notably, 60% of all purchase orders were Next Day Quotes, demonstrating strong conversion rates.The company has developed a search tool that enables quote creation within minutes, streamlining the biospecimen transaction process. The service covers various specimens, from fresh whole blood to prescreened mutation-characterized blocks, and has consistently yielded strong results in the first six months of implementation.

#ISPC iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

www.stocktitan.net/news/ISPC/i-specimen-rep...

Pete Brubaker speaking #ISPC at the Graphics Programming Conference #GPC in Breda!

News; ( NASDAQ: #ISPC ) iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

#StockMarket #News

NEWS: ( NASDAQ: #ISPC ) iSpecimen Reports Third Quarter 2024 Results

#StockMarket #News